Bank Of America Corp Longboard Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 29,255 shares of LBPH stock, worth $1.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,255

Previous 76,035 61.52%

Holding current value

$1.75 Million

Previous $2.06 Million 52.55%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.58 - $39.5 $1.29 Million - $1.85 Million	-46,780 Reduced 61.52%	29,255 $975,000
Q2 2024 Aug 14, 2024	SELL	$17.0 - $27.03 $259,913 - $413,261	-15,289 Reduced 16.74%	76,035 $2.06 Million
Q1 2024 May 15, 2024	BUY	$18.89 - $26.06 $1.37 Million - $1.9 Million	72,788 Added 392.68%	91,324 $1.97 Million
Q4 2023 Feb 14, 2024	BUY	$3.68 - $6.5 $24,111 - $42,588	6,552 Added 54.67%	18,536 $111,000
Q2 2023 Aug 14, 2023	BUY	$4.19 - $10.05 $50,212 - $120,439	11,984 New	11,984 $87,000
Q4 2022 Feb 10, 2023	SELL	$2.95 - $5.5 $16,897 - $31,504	-5,728 Reduced 99.81%	11 $0
Q3 2022 Nov 14, 2022	SELL	$2.95 - $4.7 $23,847 - $37,994	-8,084 Reduced 58.48%	5,739 $21,000
Q2 2022 Aug 12, 2022	SELL	$2.96 - $5.38 $34,170 - $62,106	-11,544 Reduced 45.51%	13,823 $42,000
Q1 2022 May 16, 2022	BUY	$4.0 - $6.0 $7,368 - $11,052	1,842 Added 7.83%	25,367 $135,000
Q4 2021 Feb 08, 2022	BUY	$4.75 - $9.45 $35,401 - $70,430	7,453 Added 46.37%	23,525 $115,000
Q3 2021 Nov 15, 2021	BUY	$8.65 - $11.36 $139,022 - $182,577	16,072 New	16,072 $142,000

Others Institutions Holding LBPH

# of Institutions

126

Shares Held

34.9M

Call Options Held

28.9K

Put Options Held

13.9K

View Full List

About Longboard Pharmaceuticals, Inc.

Ticker LBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,586,000
Market Cap $812M
Description
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...

More about LBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Longboard Pharmaceuticals, Inc. Transaction History